BCL2 and cancer: In cancer, AKT signaling pathway (Figure 1(3)) can be activated through αvβ3 integrin and promotes for example survival by targeting the pro-apoptotic Bcl-2 related protein known as Bcl-2-antagonist of cell death (BAD) [21].